aznil jurnal 1

27
By: Aznil Fajri Supervisor: dr. Nanda Earlia, Sp. KK

Upload: muhammad-rizki-ramadana

Post on 13-Apr-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 1/27

By:Aznil Fajri

Supervisor:

dr. Nanda Earlia, Sp. KK

Page 2: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 2/27

  bstract

The etiopathogenesis of perioraldermatitis (PD) is still unknown andconsequently, medical treatment is

difficult,.

neurogenic inflammation could playa role in the pathogenesis of PD, as

many cutaneous diseases.

PD seems to be mainly related to themercury contained in dental fillings

and/or its organic compounds formedby oral/gut bacteria.

the possible role of thesesubstances as causes of PD,

providing new information on thepossible cross-talk between

neuroimmunodermatology andpotential triggers of PD.

Page 3: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 3/27

Introduction

Perioral dermatitis (PD) is classically

characterized by perioral papules and

pustules sparing a narrow zone around

the lips.

Clinically polymorphic presentations,

including papulovesicles and erythematous-

eczcematous and scaling eruption, are

frequently reported.

Many exogenous and endogenous factors

have been proposed as possible causative

agents, but the etiopathogenesis is still

unknown.

Page 4: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 4/27

Case Report

erythematous-eczematous, nonitching, perioral

lesions, which appeared 6 weeks earlier

filling of three molars performed 2 months earlier, hadcaused mild pain and local inflammation in the filling

sites

redness and edema surrounding the aforementionedteeth, and a localized pain in the filling sites

Page 5: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 5/27

Case Report

Use of topical or systemic drugs in the last 3 months,

as well as recent prolonged UV exposure, use of

cosmetics, or use of toothpaste were denied

Routine blood exams, thyroid and sex hormones were

normal, Lesional microbial and fungal flora were quali-

quantitatively normal

Patch test (Tabel 1) : a single sensitization (++) to

thiomersal (sodium ethylmercury thiosalicylate)

Page 6: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 6/27

TABLE 1 Haptens Used for First (A) and Second (B) Patch Test in our Patient.

(A) First Patch Test

Thiuram mix 1% Neomycin sulfate 20%

Nickel sulfate 5% Colophony 20%

Phenol-formaldehyde resin 5% Ethylenediamine 1%

Balsam of Peru 25% Fragrance mix 8%

Lanolin alcohols 30% Potassium dichromate 0.5%

p-Phenylenediamine 1% Mercaptobenzothiazole 2%

Epoxy resin 1% Disperse blue 1%

Disperse yellow 1% Disperse red 1%

Disperse orange 1% Paraben mix 15%

Kathon CG 0.01% (in water) Formaldehyde 1% (in water)

Benzocaine 5% Cobalt chloride 1%Thiomersal 0.1% Diaminodiphenylmethane 0.5%

Carba mix 3% Mercaptobenzothiazole mix (MBT mix) 2%

Quaternium-15 1% Mercury ammonium chloride 1%

Quinoline mix 6% Imidazolidinyl urea 1%

Phenylisopropylparaphenylenediamine 0.1% p-Toluenediamine 1%

Page 7: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 7/27

Hydrocortisone-17-butyrate 1% (in

ethanol) Budesonide 0.1%

Ketoprofen 10% Latex 0.1% (in water)

Tegobetaine 1% (in water) Euxyl K 400 1.5%

Compositae mix 5% Propylene glycol 10% (in water)

Diphenylguanidine 1% Hexamethylenetetramine 1%

Hydroquinone-monobenzylether 1% Palladium chloride 1%

Eugenol 5% Hydroquinone 1%Mercury 0.5% Ethylene glycol dimethacrylate 2%

Methyl methacrylate 5% Bisphenol A dimethacrylate 2%

Propolis 20% Sorbic acid 5%

Butylated hydroxyanisole 2% Alpha-tocopherol 20%

(B) Second Patch Test 

Tin 2.5% Colloidal silver 0.1%

Tin chloride 1% Zinc 2.5%

Copper sulfate 1% (in water) Zinc chloride 2%

Silver nitrate 1% (in water) Zinc sulfate 2%

Page 8: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 8/27

Case Report

lesions overlapped with the facial areas innervated by

infraorbitary nerves and right mental nerve

Page 9: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 9/27

Case Report

these nerves also innervate the dental half arcs that

contained the amalgam-filled molars

new lesions in the facial area innervated by the left

mental nerve

Page 10: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 10/27

Discussion

Page 11: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 11/27

This case appears as a good model ofneuroinflammation: the distribution oflesions supports the idea of

neuroinflammation involving trigeminalbranches that innervate teeth and

perioral skin.

The amalgam seems the mostprobable trigger, through two possiblemechanisms, not mutually exclusive

(see top panel fig. 3)

Direct effect of mercury released by theamalgam (and/or methylmercury,

synthesized from inorganic mercury by

oral bacteria) on neuronalfunction/excitability and/or cholinergicreceptors/pathways— Several papersindicate the possible involvement of thecholinergic system during intoxicationby mercury and/or organomercurials.

Page 12: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 12/27

FIGURE 3. Schematicre presentationof possible pathogenic mechanisms

involving the cholinergic system in

neurogenic inflammation.

Page 13: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 13/27

Methylmercury, synthetized from amalgam-derived inorganic

mercury by oral and gut bacteria, could have elicited type IVhypersensitivity reactions in our patient, leading to release of

mediators causing/worsening neuroinflammation.

Nerve stimulation could cause perioral skin neuroinflammation

through antidromic signal conduction on a specially branching set

of nociceptors connecting the alveolar cavity and the face(classic axon reflex), and/or through an indirect mechanism

related to central processing of the trigeminal signal followed by

involvement of autonomic parasympathetic fibers.

Page 14: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 14/27

Conclution

the role of neuroinflammation in PD is worthy of

investigation. Apart from the present case,

neuroinflammation could play a role, more in general,

in the pathogenesis of perioral dermatoses and,

possibly, oral lichenoid reactions in patients allergic todental filling metals. The cholinergic system seems

crucial in the communication between oral mucosa,

nerves, and the immune system in skin diseases.

Page 15: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 15/27

Thanks......Thank you 

Page 16: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 16/27

Telaah Kritis Diagnosis Dini

1.  Apakah jika prosedur diagnosis dini dilaksanakan

akan dapat memperbaiki hasil akhir dari pada

perjalanan klinik penderita?

Ya

b) Tidak

c) Tak iketahui

Page 17: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 17/27

2. Jika hasil pemeriksaan dini positif, apakah kita

dapat meluangkan waktu tambahan yang

diperlukan untuk konfirmasi diagnosis pasti

maupun jika diperlukan perawatan jangka lama?

Ya

b) Tidak

c) Tak iketahui

Page 18: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 18/27

3. Apakah penderita dengan hasil test diagnisis dini

yang positif dapat mengikuti program pengobatan

yang akan diberikan sesuai dengan penyakit

tersebut?

a) Ya

Tidak

c) Tak iketahui

Page 19: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 19/27

4. Apakal telah ada bukti pemeriksaan kesehatan

berkala dengan menggunakan test tunggal lebih

baik dibandingkan dengan menggunakan

beberapa test?

a) Ya

Tidak

c) Tak iketahui

Page 20: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 20/27

5. Apakah ada kecacatan yang tersembunyi akibat

penyakit tersebut membutuhkan tindakan medik

yang nyata?

Ya

b) Tidak

c) Tak iketahui

Page 21: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 21/27

6. Apakah test screening yang akan digunakan

cukup adekuat dalam segi biaya, akurasi, dan

aseptabilitasnya?

a) Ya

Tidak

c) Tak iketahui

Page 22: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 22/27

Telaah Kritis Screening Test

1.  Apakah metode penelitian suatu randomized

trial?

a) Ya

Tidakc) Tak iketahui

Page 23: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 23/27

2. Apakah ada pengobatan yang efektif untuk

kelainan tersebut?

Ya

b) Tidakc) Tak iketahui

Page 24: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 24/27

3. Apakah ada sesuatu hal tersembnyi pada penyakit

tersebut yang memerlukan screening?

a) Ya

Tidak

c) Tak diketahui

Page 25: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 25/27

4. Apakah screening test mempunyai angka

sensitifitas dan spesifisitas yang tinggi?

Ya

b) Tidakc) Tak iketahui

Page 26: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 26/27

5. Dapatkah sistem kesehatan (skala nasional atau

profesi) selaras dengan program test yang akan

dilaksanakan?

Ya

b) Tidak

c) Tak iketahui

Page 27: aznil jurnal 1

7/27/2019 aznil jurnal 1

http://slidepdf.com/reader/full/aznil-jurnal-1 27/27

6. Apakah hasil test yang positif memerlukan

tindakan lanjutan berupa tindakan intervensi, atau

pemeriksaan lanjutan?

Ya

b) Tidak

c) Tak iketahui